Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 351 to 375
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
PublicationsA rapid literature review of safety and performance issues
-
PublicationsGuidance for reducing assessment fees for ARTG application audits and TGA conformity assessments of medical devices (including IVDs).
-
Scheduling decisions (final)Notice of NCE to be included in Schedule 4 of the Poisons Standard
-
PublicationsThe report card shows the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
TGA Laboratories testing report: Microbiological testing of medicines containing Green-lipped Mussel
TGA laboratory testing reportsTGA Laboratories Branch has released a report summarising the microbiological testing of green-lipped mussel products -
Meeting statementsAdvisory Committee on Biologicals
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 9 July 2020
-
Meeting statementsCommunique from the meeting of the TGACC
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 19 March 2020
-
Scheduling decisions (final)NCEs to be included in the June 2020 Poisons Standard
-
-
Scheduling submissionsPublic submissions on matters referred to the November 2019 scheduling meetings, and received during the interim consultation period
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend the Poisons Standard
-
PublicationsStatistical information for 1 July to 31 December 2019 in relation to our regulation of therapeutic goods
-
PublicationsIn 2019, the TGA conducted 10 pharmacovigilance inspections of Australian medicine sponsors
-
Meeting statementsThe TGACC meeting was held on 20 Feb 2020, a communique has been published
-
Scheduling decisions (final)Poisons Standard amendments to hydroxychloroquine to ensure continued availability during the COVID-19 pandemic
-
Scheduling decisions (final)Amendments in relation to hydroxychloroquine and salbutamol
-
TGA laboratory testing reportsUpdates have been made to the previously published report related to the testing of HPV vaccines available in Australia
-
PublicationsThis report describes the first 12 months of the mandatory reporting scheme
-
PublicationsThe TGA thanks respondents who provided a submission in response to the public consultation paper
-
Meeting statementsThe Advisory Committee on Biologicals (ACB) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990